Opendata, web and dolomites


ADAPTOS - Changing the way bone voids are treated

Total Cost €


EC-Contrib. €






Project "ADAPTOS" data sheet

The following table provides information about the project.


Organization address
address: TAKAMAANTIE 4 A 4
postcode: 33960
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 3˙212˙500 €
 EC max contribution 2˙248˙750 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2021-09-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOMENDEX OY FI (PIRKKALA) coordinator 2˙248˙750.00


 Project objective

There are 4 million operations performed annually that require a bone graft. This makes bone the second most common tissue transplant in the world, trailing only blood transfusions.

There are three options where to source the bone today. Directly from the patient (autograft), from a bone bank (allograft) or using a substitute. The dominant method today is autografting. This is because human’s own bone is easy to use and offers plentiful regeneration properties.

However, autografting is painful and risky, causing complications in 50% of harvests. This has caused orthopaedic surgeons to regard autografting as a trade-off between sourcing a suitable bone at the cost of a minor disability for the patient. This is where Adaptos comes in. Adaptos is the only bone graft substitute that mimics bone by being resilient and bioactive. Adaptos gives surgeons the freedom to operate, as they were using autografts, without the drawbacks.

Today, Adaptos is already in use across 9 animal clinics. By collaborating with numerous surgeons, we have validated our technology as the best bone graft substitute on the market.

We will initially enter the synthetic bone graft substitute market valued at €2.1 billion. We aim to penetrate the less complex markets first (animals, craniomaxillofacial & orthopaedic applications). Through these applications, we will build reference cases to meet the high burden-of-proof required to enter the most complex applications (e.g. Spinal fusion).

Our cross-disciplinary founding team will use the SME-project to scale up Adaptos’ production line, build reference cases across 3 hospitals via a multi-country clinical trial and improve our onboarding of orthopaedic surgeons in the process.

Thanks to the SME-project, we estimate that we will reach €17 million in revenue by 2023 while employing 35 high-quality employees.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ADAPTOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ADAPTOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More